Vimarsana
Biggest News Aggregation in the World

Page 5 - Previously Reported News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Previously Reported. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Previously Reported Today - Breaking & Trending Today

Flying Nickel's Minago Drill Core PGM Assay Program Returns 22.8 Meters Grading 0.73g/t Platinum+Palladium+Gold in Addition to Previously Reported 1.45% Nickel in the Thompson Nickel Belt in Manitoba - Vimarsana News

Flying Nickel's Minago Drill Core PGM Assay Program Returns 22.8 Meters Grading 0.73g/t Platinum+Palladium+Gold in Addition to Previously Reported 1.45% Nickel in the Thompson Nickel Belt in Manitoba

Flying Nickel Mining Corp. is pleased to announce the initial platinum-group-metals assay results from the Company's 100% owned Minago Nickel PGM project in Thompson Nickel Belt in Manitoba. Further to the news release dated January 17, 2023, the... - Veroeffentlicht am 30.03.2023

In 2022, the Aurum Group enterprises paid about 162 million hryvnias in tax - Vimarsana News

In 2022, the Aurum Group enterprises paid about 162 million hryvnias in tax

The company’s losses amounted to more than 10 million hryvnias

РФ стягивает войска в Сватово и Троицкое - Гайдай - Vimarsana News

РФ стягивает войска в Сватово и Троицкое - Гайдай

Оккупанты готовятся к оборонительным боям в Луганской области, блицкрига как на Харьковщине не будет.

Пенсионер МВД задержан: появились новые подробности загадочного убийства женщины с собакой в Новой Москве - Vimarsana News

Пенсионер МВД задержан: появились новые подробности загадочного убийства женщины с собакой в Новой Москве

Следователи полагают, что Юрий Новиков заранее спланировал убийство супруги.

Source: bloknot.ru
Atara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expan - Vimarsana News

Atara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expan

Overall Response Rate (ORR) of 60% Observed in Patients with Relapsed or Refractory (R/R) EBV+ PTLD Consistent with Previously Reported StudiesCompletion of All Pre-Approval Inspections Required to Support EU Marketing Authorization Application; Anticipated European Commission Approval On-Track for Q4 2022SOUTH SAN...